Effect of augmentation with olanzapine in outpatients with depression in partial remission with melancholic features: Consecutive case series

Psychiatry and Clinical Neurosciences

Volumn 65, Issue 2, 2011, Pages 199-202

  Nozawa, Koji ^a   Sekine, Atsushi ^b   Hozumi, Satoshi ^b   Shimizu, Tetsuo ^c  

^a Yamamoto Kumiai General Hospital   (Japan)

^b Kyowa Hospital   (Japan)

^c AKITA UNIVERSITY   (Japan)

Author keywords

affective disorders; medicine; pharmacopsychiatry; primary care; psychiatry

Indexed keywords

FLUVOXAMINE; IMIPRAMINE; MILNACIPRAN; OLANZAPINE; PAROXETINE; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DROWSINESS; DRUG EFFECT; FEMALE; HUMAN; MALE; MELANCHOLIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTPATIENT; REMISSION; SEDATION; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS;

EID: 79952914184     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2010.02184.x     Document Type: Article

References (14)

1. Angst J,. Major depression in 1998: Are we providing optimal therapy? J. Clin. Psychiatry 1999; 60: 5-9. (Pubitemid 29210624)
2. Tollefson GD, Sanger TM, Beasley CM, Tran PV,. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Biol. Psychiatry 1998; 43: 803-810. (Pubitemid 28288378)
3. Tran PV, Hamilton SH, Kuntz AJ, et al,. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J. Clin. Psychopharmacol. 1997; 17: 407-418. (Pubitemid 27414397)
4. Takahashi H, Kamata M, Yoshida K, Higuchi H, Ishigooka J,. Augmentation with olanzapine in TCA-refractory depression with melancholic features: A consecutive case series. Hum. Psychopharmacol. 2008; 23: 217-220. (Pubitemid 351577691)
5. Shelton RC, Williamson DJ, Corya SA, et al,. Olanzapine/fluoxetine combination for treatment-resistant depression: A controlled study of SSRI and nortriptyline resistance. J. Clin. Psychiatry 2005; 66: 1289-1297. (Pubitemid 41546509)
6. Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G,. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression. Depress. Anxiety 2006; 23: 364-372. (Pubitemid 44619788)
7. Montgomery SA, Asberg M,. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979; 134: 382-389. (Pubitemid 9136500)
8. Shioe K, Hirano M, Kanba S,. The treatment algorithm of major depressive disorders. In:, Ohhashi N, (ed.). Pharmacological Treatment Algorithm of Mood Disorder. Jihou, Tokyo, 2003; 19-46.
9. Binder RL, Levy R,. Extrapyramidal reactions in Asians. Am. J. Psychiatry 1981; 138: 1243-1244. (Pubitemid 11095721)
10. Zimmerman M, Posternak MA, Cheminski I,. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J. Psychiatr. Res. 2004; 38: 577-582. (Pubitemid 39348889)
11. Montgomery SA, Andersen HF,. Escitalopram versus venlafaxine XR in the treatment of depression. Int. Clin. Psychopharmacol. 2006; 21: 297-309. (Pubitemid 44162482)
12. Li XM, Perry KW, Wong DT, Bymaster FP,. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 1998; 136: 153-161. (Pubitemid 28137955)
13. Huang CC, Shiah IS, Chen HK, Mao WC, Yeh YW,. Adjunctive use of methylphenidate in the treatment of psychotic unipolar depression. Clin. Neuropharmacol. 2002; 31: 24-57.
14. Matthews JD, Bottonari KA, Polania LM, et al,. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: Interim analyses. J. Clin. Psychiatry 2002; 63: 1164-1170. (Pubitemid 36084062)